MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to zentalis
-$137,060K
(17.35%↑ Y/Y)
Net loss
-$137,060K
(17.37%↑ Y/Y)
Net loss before
income taxes
-$136,618K
(17.55%↑ Y/Y)
Income tax expense
(benefit)
$442K
(149.72%↑ Y/Y)
Investment and other
income, net
$16,190K
(-36.52%↓ Y/Y)
Loss from operations
-$152,808K
(20.08%↑ Y/Y)
Total operating
expenses
$152,808K
(-40.91%↓ Y/Y)
Research and development
$107,295K
(-36.05%↓ Y/Y)
General and
administrative
$37,717K
(-56.70%↓ Y/Y)
Restructuring
$7,796K
Accruals
$6,990K
Non-cash items
$806K
Back
Back
Income Statement
source: myfinsight.com
Zentalis Pharmaceuticals, Inc. (ZNTL)
Zentalis Pharmaceuticals, Inc. (ZNTL)